Efficacy and Safety of Erenumab in Patients with Chronic Migraine Who Have Experienced Preventive Treatment Failure
ByAshina M, Tepper S, Brandes JL, et al. Efficacy,safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: a subgroup analysis of a randomized, double-blind, placebo-controlled study [published online January 1, 2018]. Cephalalgia. doi: 10.1177/0333102418788347.
